OneSpaWorld Holdings (OSW) Earnings Analysis
OneSpaWorld Holdings (OSW) next reports earnings on 2026-07-29, consensus EPS 0.29 USD. Last quarter (2026-04-29) it beat with EPS 0.27 USD vs 0.25 USD est (+8%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E 34.16.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OSW next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | 0.29 USD |
| Revenue estimate | 0.26B |
OSW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-29 | 0.27 USD | 0.25 USD | +8% | Beat |
| 2026-02-18 | 0.24 USD | 0.26 USD | -7.7% | Miss |
| 2025-10-29 | 0.29 USD | 0.29 USD | 0% | Beat |
| 2025-04-30 | 0.22 USD | 0.21 USD | +4.8% | Beat |
| 2025-02-19 | 0.2 USD | 0.21 USD | -4.8% | Miss |
| 2024-10-30 | 0.26 USD | 0.23 USD | +13% | Beat |
| 2024-07-31 | 0.2 USD | 0.2 USD | 0% | Beat |
Beat rate: 5/7 (71%) over reported quarters with consensus data.
OSW valuation and analyst view
| Trailing P/E | 34.16 |
|---|---|
| Trailing EPS | 0.76165 USD |
| Price / book | 4.71 |
| Dividend yield | 0.73% |
| Market cap | 2.66B |
| Analyst consensus | Buy (10 buy / 1 hold / 0 sell) |
| Avg price target | 30.67 USD |
Related research pages
Frequently asked questions
When is OneSpaWorld Holdings (OSW)'s next earnings date?
OneSpaWorld Holdings is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 0.29 USD and revenue estimate of 0.26B.
Did OSW beat earnings last quarter?
In its 2026-04-29 report, OSW posted EPS of 0.27 USD versus a 0.25 USD estimate — a beat of 8%.
What is OSW's earnings track record?
Over the last 7 reported quarters with consensus data, OSW beat estimates 5 times (71%).
What is OSW's current P/E ratio and EPS?
OSW trades at a trailing P/E of 34.16 on trailing EPS of 0.7616512232191008 USD.
What do analysts rate OSW?
Analyst consensus is "Buy" across 11 ratings (0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 30.67 USD.